The number of CD3+ and CD8+ tumor-infiltrating lymphocytes was increased in HR pathway deficient cells, whereas BRCA1/2 mutated tumors also showed increased infiltration of CD4+ cells [22]. This evidence concerns the gene CD8A and neoplasm.